Lethal short-bowel syndrome

Area of Science:

• Pediatric surgery
• Gastroenterology
• Neonatal intensive care

Background:

• Short bowel syndrome (SBS) in infants presents significant management challenges.
• Current supportive measures including parenteral nutrition and surgical interventions offer limited success.
• Severe SBS often leads to poor prognoses and high mortality rates.

Purpose of the Study:

• To review outcomes of infants diagnosed with severe short bowel syndrome.
• To evaluate the efficacy of current management strategies for SBS.
• To determine prognostic indicators for survival in infants with SBS.

Main Methods:

• Retrospective review of seven infants with severe SBS.
• Analysis of causes including volvulus, atresias, and intestinal aganglionosis.
• Documentation of surgical procedures, total parenteral nutrition (TPN) duration, and survival times.

Main Results:

• Survival ranged from 15 days to 8 months, with death averaging 9 weeks post-diagnosis.
• Infants with less than 6 cm of small bowel beyond the Ligament of Treitz had an inevitably fatal outcome.
• TPN-related complications, including liver dysfunction and failure, were observed in multiple infants.

Conclusions:

• Severe SBS in infants, particularly with limited bowel length (<6 cm), is associated with a grim prognosis.
• While interventions may prolong survival, they do not alter the ultimate outcome and increase morbidity.
• Withholding further therapy upon diagnosis may be a reasonable consideration given the limited therapeutic options and poor prognosis.